Statins for Primary Prevention: The Debate Is Intense, but the Data Are Weak

JAMA. 2016 Nov 15;316(19):1979-1981. doi: 10.1001/jama.2016.15085.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cardiovascular Diseases / drug therapy
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Primary Prevention*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors